Literature DB >> 7466402

Fluorocarbons reduce myocardial ischemic damage after coronary occlusion.

D H Glogar, R A Kloner, J Muller, L W DeBoer, E Braunwald, L C Clark.   

Abstract

Open-chest, anesthetized dogs with occlusions of the left anterior descending coronary artery breathed 100 percent oxygen while they were bled to a hematocrit of 25 percent and infused with an approximately equal volume (40 milliliters per kilogram) of fluorocarbon preparation or Ringer solution. Dogs breathing room air and receiving no treatment served as controls. After undergoing 6 hours of coronary occlusion, animals bled and treated with fluorocarbons developed smaller infarctions than those receiving Ringer solution or no treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7466402     DOI: 10.1126/science.7466402

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Effect of a perfluorochemical emulsion on the development of artificial lung metastases in mice.

Authors:  S Rockwell; C G Irvin; M Nierenburg
Journal:  Clin Exp Metastasis       Date:  1986 Jan-Mar       Impact factor: 5.150

2.  Artificial blood.

Authors:  P M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

Review 3.  Blood component therapy in anaesthetic practice.

Authors:  M A Blajchman; R Herst; R A Perrault
Journal:  Can Anaesth Soc J       Date:  1983-07

Review 4.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

5.  Effect of two perfluorocarbon emulsions on reperfusion injury after coronary artery occlusion in rabbits.

Authors:  S L Hale; H Hammerman; R A Kloner
Journal:  Basic Res Cardiol       Date:  1995 Sep-Oct       Impact factor: 17.165

Review 6.  Current status of erythrocyte substitutes.

Authors:  G P Biro
Journal:  Can Med Assoc J       Date:  1983-08-01       Impact factor: 8.262

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.